Prognostic Value of Angiography-Derived Index of Microcirculatory Resistance
Study Overview
This study investigates how the angiography-derived index of microcirculatory resistance (angio-IMR) relates to outcomes in patients with intermediate coronary stenosis.
Key Findings
- The study involved 1,658 patients from the FLAVOUR trial.
- Patients were monitored for 24.8 months on average.
- Those with angio-IMR >25 had a higher rate of serious outcomes, including death and heart attacks.
- Angio-IMR >25 was a strong predictor of poor outcomes, regardless of treatment type.
Practical Solutions and Value
Using angio-IMR can help doctors:
- Identify patients at higher risk for serious health issues.
- Make better treatment decisions based on individual risk profiles.
- Improve patient outcomes through targeted interventions.
Clinical Application
Integrating angio-IMR into clinical practice enhances risk assessment and patient management.
About DocSym
DocSym is an AI-driven platform that helps clinicians access essential knowledge, including:
- ICD-11 standards
- Clinical protocols
- Research findings
Our mobile apps streamline operations by supporting scheduling, treatment monitoring, and telemedicine, making patient care more efficient.
Learn more about how we can assist you at aidevmd.com.
